Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Lorlatinib is a targeted therapy indicated for the treatment of ALK-positive non···【more】
Release date：2026-01-26Recommended：115
Lorlatinib is a targeted therapy indicated for the treatment of specific ALK or ···【more】
Release date：2026-01-26Recommended：158
The common adverse reactions of Lorlatinib include metabolic abnormalities, cent···【more】
Release date：2026-01-26Recommended：110
The side effects of lorlatinib involve multiple systems, including the central n···【more】
Release date：2026-01-26Recommended：126
Lorlatinib is a third-generation anaplastic lymphoma kinase (ALK)/c-ros oncogene···【more】
Release date：2026-01-23Recommended：120
Lorlatinib is a third-generation dual-target inhibitor of ALK/ROS1, primarily in···【more】
Release date：2026-01-23Recommended：93
The price of lorlatinib varies significantly, mainly depending on the drug sourc···【more】
Release date：2026-01-23Recommended：83
This drug is a prescription medicine. Its use must strictly follow the doctor’s ···【more】
Release date：2026-01-23Recommended：87
The price of Lorlatinib is subject to significant fluctuations due to the impact···【more】
Release date：2026-01-23Recommended：71
The monthly treatment cost of lorlatinib currently available in China fluctuates···【more】
Release date：2026-01-23Recommended：98
Pfizer recently announced that the U.S. Food and Drug Administration (FDA) has a···【more】
Release date：2026-01-23Recommended：122
On March 3, 2021, Pfizer announced that the U.S. Food and Drug Administration (F···【more】
Release date：2026-01-23Recommended：131
